Here’s what you should know about PSA screening, why medical guidelines vary and why individualized approaches are essential ...

S EEN THROUGH the cold lens of statistics, Joe Biden’s statement on May 18th that he had been diagnosed with prostate cancer ...

The combination of enzalutamide with androgen deprivation therapy (ADT) significantly increases the chance of five-year survival for men with metastatic hormone-sensitive prostate cancer, according to ...

Ed Burgess, diagnosed with stage IV prostate cancer, shares his journey of survival thanks to a combination of hormone therapy and the drug enzalutamide, highlighting the personal impact of research ...